purine has been researched along with febuxostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hisaka, A; Kurebayashi, N; Miyano, K; Nonaka, M; Sakurai, T; Sato, H; Uezono, Y; Uzu, M; Yanagihara, K | 1 |
| Busso, N; Kobayashi, T; Nomura, J; So, A | 1 |
2 other study(ies) available for purine and febuxostat
| Article | Year |
|---|---|
A novel strategy for treatment of cancer cachexia targeting xanthine oxidase in the brain.
Topics: Administration, Oral; Animals; Brain; Cachexia; Disease Models, Animal; Febuxostat; Male; Mice, Inbred BALB C; Neoplasms; Purines; Xanthine Oxidase | 2019 |
Febuxostat, a Xanthine Oxidoreductase Inhibitor, Decreases NLRP3-dependent Inflammation in Macrophages by Activating the Purine Salvage Pathway and Restoring Cellular Bioenergetics.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Energy Metabolism; Febuxostat; Humans; Inflammasomes; Inflammation; Macrophages; Mice; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Primary Cell Culture; Purines; Reactive Oxygen Species; Xanthine Dehydrogenase | 2019 |